Sale!

VOSEVI Drug Profile, 2024

Original price was: $800.00.Current price is: $399.00.

VOSEVI (sofosbuvir; velpatasvir; voxilaprevir) drug patents, litigation, PTAB cases, SPCs, clinical trials, suppliers

SKU: VOSEVI Category:
Originally published at https://www.chemintel360.com/. Get our excipient business reports at https://chemintel360.com/product-category/excipients/, and our drug patent reports at https://chemintel360.com/product-category/drug-patent-reports/

VOSEVI Drug Profile, 2024 is part of DrugPatentWatch’s deep library of business intelligence on biopharmaceutical drugs.

This definitive guide provides invaluable business insights into every crucial aspect of this medication, addressing the vital points necessary to make business decisions.

Gain key critical insights for VOSEVI:

  • United States patents
  • District Court patent litigation
  • Patent Trial and Appeal Board (PTAB) patent cases
  • European supplementary protection certificates (SPCs)
  • Clinical trials
  • Finished product suppliers
Pages

79

Product

VOSEVI

ChemIntel360
Scroll to Top